A class-action suit against pharmaceutical Pfizer Inc. and Pfizer Canada Inc. has been approved by a Quebec Superior Court Justice. The suit is to be brought by women who have taken the contraceptive Depo-Provera.
Depo-Provera, which received a U.S. Food and Drug Administration black box warning, is an injectable that protects against pregnancy for a period of three months and has also been used in treatment of breast and endometrial cancer and endometriosis.
Pfizer issued a public notification in 2005 stating that two clinical trial results showed that the drug may cause users to experience a reduction in bone mineral density especially in menopausal women.
Any Canadian women who took the drug and believes they have suffered bone density loss are eligible to join in the class action suit against Pfizer. The case is Noelia Brito v. Pfizer Canada Inc., 500-06- 000305-058, Quebec Superior Court of Justice (Montreal).
[Source: Bloomberg]
Comment Preview